Caricamento...
Combined Atezolizumab and Chemotherapy for a Patient With Double Primary Cancers
Background: Immune checkpoint inhibitors are indicated for non-small cell lung cancer (NSCLC) and head and neck cancer, and combined treatment of immune checkpoint inhibitor and chemotherapy has recently been carried out in patients with NSCLC. However, there is no established standard therapy for s...
Salvato in:
| Pubblicato in: | In Vivo |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
International Institute of Anticancer Research
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984065/ https://ncbi.nlm.nih.gov/pubmed/31882503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11785 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|